Comparison of the Efficacy and Safety of Two Topical Creams for Pediatric Atopic Dermatitis

A Randomized, Investigator-Blind, Six-Week, Parallel Group, Multicenter Pilot Study to Compare the Safety and Efficacy of EpiCeram Skin Barrier Emulsion and Desonide Cream 0.05% in the Twice Daily Treatment of Pediatric Subjects With Moderate Atopic Dermatitis

This study compares the effectiveness of two topical creams for atopic dermatitis in pediatric subjects. Subjects will be randomly assigned to use one of the two creams twice daily for 6 weeks or until clear.

Inclusion Criteria:

• at least 3 months of age and less than 13 years of age
• atopic dermatitis of moderate severity

Exclusion Criteria:

• pregnant or lactating
• treatment of atopic dermatitis with topical product in the 14 days prior to Baseline
• treatment of atopic dermatitis with systemic product in the 30 days prior to Baseline
• serious or uncontrolled medical condition
• active infection
• significant use of inhaled, intranasal, or intraocular corticosteroid